Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Change in Receivables (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Change in Receivables for 15 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 56.46% year-over-year to $4.7 million, compared with a TTM value of $1.6 million through Dec 2025, down 83.38%, and an annual FY2025 reading of $1.6 million, down 83.38% over the prior year.
  • Change in Receivables was $4.7 million for Q4 2025 at Orthofix Medical, up from $2.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $13.3 million in Q4 2023 and bottomed at -$5.4 million in Q1 2022.
  • Average Change in Receivables over 5 years is $1.8 million, with a median of -$78000.0 recorded in 2022.
  • The sharpest move saw Change in Receivables surged 1143.63% in 2023, then plummeted 2731.07% in 2025.
  • Year by year, Change in Receivables stood at $9.8 million in 2021, then plummeted by 30.6% to $6.8 million in 2022, then soared by 96.33% to $13.3 million in 2023, then fell by 18.73% to $10.8 million in 2024, then crashed by 56.46% to $4.7 million in 2025.
  • Business Quant data shows Change in Receivables for OFIX at $4.7 million in Q4 2025, $2.0 million in Q3 2025, and -$2.7 million in Q2 2025.